Aptamer Sciences Inc (KOSDAQ:291650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,109.00
-69.00 (-5.86%)
At close: Jan 29, 2026

Aptamer Sciences Revenue

In the year 2024, Aptamer Sciences had annual revenue of 1.08B KRW with 345.26% growth. Aptamer Sciences had revenue of 920.07M in the quarter ending December 31, 2024, with 5,471.58% growth.

Revenue
1.08B
Revenue Growth
+281.58%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
44.65B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.08B839.63M345.26%
Dec 31, 2023243.19M-115.07M-32.12%
Dec 31, 2022358.25M88.98M33.04%
Dec 31, 2021269.28M40.77M17.84%
Dec 31, 2020228.51M-179.09M-43.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
J2KBIO31.12B
Ark Solutions21.50B
PanGen Biotech15.27B
ADBiotech14.57B
NGeneBio9.98B
MOA Life Plus9.80B
EyeGene4.10B
SunBio,Inc.2.17B
Revenue Rankings